Non-alcoholic fatty liver disease in Women – Current Knowledge and Emerging Concepts
نویسندگان
چکیده
Non-alcoholic fatty liver disease (NAFLD) is a major cause of worldwide, affecting up to 30% adults. Progression non-alcoholic steatohepatitis (NASH) key risk factor for cirrhosis, hepatocellular carcinoma and cardiovascular events. Alterations in reproductive hormones are linked the development and/or progression NAFLD/NASH women. Women with Polycystic Ovary Syndrome (PCOS) those estrogen deficiency at increased NAFLD/NASH, higher mortality rates older women compared men similar ages. currently leading indication transplantation without carcinoma. Therefore, better understanding NAFLD needed improve outcomes. In this review, we discuss hormonal non-hormonal factors contributing Furthermore, highlight areas focus clinical practice future research.
منابع مشابه
Non-alcoholic fatty liver disease: current concepts and management strategies.
Non-alcoholic fatty liver disease (NAFLD), the liver manifestation of the metabolic syndrome, is now considered to be the commonest liver problem in the western world. This apparent 'epidemic', coupled with an accumulating body of evidence that a significant proportion of patients with NAFLD can progress to cirrhosis, liver failure and hepatocellular carcinoma (HCC), has--perhaps not surprising...
متن کاملClinical Manifestations and Diagnosis of Non-Alcoholic Fatty Liver Disease
Background & Objective: Nonalcoholic fatty liver diseases (NAFLD) is the major cause of hepatocellular carcinoma and increases the risk of mortality. Understanding the trends of its clinical and biochemical changes is essential to identify patients with NAFLD that are at the greatest risk of nonalcoholic steatohepatitis (NASH) and cirrhosis in Iran. M...
متن کاملNon-alcoholic fatty liver and cardiovascular disease: an emerging relationship.
N on-alcoholic fatty liver disease (NAFLD) is a clinicopathological condition characterised by a wide spectrum of histological abnormalities and clinical outcomes. The underlying histological abnormality is hepatic steatosis, characterised by fat accumulation, which may progress to non-alcoholic steatohepatitis (NASH), characterised in turn by steatosis, periportal inflammation, and ballooning ...
متن کاملCurrent solutions for obesity-related liver disorders: non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
o besity is a worldwide epidemic with more than 1 billion overweight adults and at least 300 million obese patients [1]. According to recent statistics from the United States, 16.9% of children and adolescents aged 2–19 years were obese in 2009–2010 and 31.8% were either overweight or obese [2]. The rise in childhood obesity has been accompanied by an increase in pediatric liver diseases: 70%–8...
متن کاملDiagnosis and classification of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Current concepts and remaining challenges.
The high prevalence of non-alcoholic fatty liver disease (NAFLD) has made the condition an important public health issue. Two clinical entities are manifestations of NAFLD, namely, non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH). The former tends to be benign and non-progressive while the latter can progress to cirrhosis, which in rare cases gives rise to hepatocellula...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JHEP reports
سال: 2023
ISSN: ['2589-5559']
DOI: https://doi.org/10.1016/j.jhepr.2023.100835